FDA Inspection 996509 — Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc.

Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc. — FEI 1971534

The FDA completed an inspection of Community Blood Center of Greater Kansas City, an Operating Division of New York Blood Center, Inc. on December 15, 2016 in Topeka, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 15, 2016
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Topeka, KS (United States)